Alejandra Contreras-Ramos

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Pharmaceuticals (Basel, Switzerland)

Molecular biology reports

Journal of oncology

Microorganisms

Hospital Infantil de México Federico Gomez

Universidad de Jaén (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Infantil de México Federico Gomez Jan 01 2015

Mexico

RESEARCH ASSOCIATE D :: BIOLOGIA DEL DESARROLLO Y T. E.

Hospital Infantil de México Federico Gomez Jan 01 2010 - Dec 31 2014

Mexico

RESEARCH ASSOCIATE C :: BIOLOGIA DEL DESARROLLO Y T. E,

Hospital Infantil de México Federico Gomez Jan 01 2008 - Dec 31 2009

Mexico

research associate B :: biologia del desarrollo y T.E.

Hospital Infantil de México Federico Gomez Jan 01 2003 - Dec 31 2007

Mexico

Chemist A :: BIOLOGIA DEL DESARROLLO Y T.E.

Education History

Universidad de Jaén Sep 01 2008 - Jul 31 2009

Spain

MSC :: BIOLGY

Universidad Autónoma Metropolitana Iztapalapa Jan 01 2004 - Aug 31 2007

Mexico

PHD :: EXPERIMENTAL BIOLOGY

Instituto Politécnico Nacional Escuela Superior de Medicina Sep 01 2000 - Jul 31 2002

Mexico

MSC :: MORPHOPHYSIOLOLOGY

Publications

Ricardo Ivan Cordova-Chávez, José Guadalupe Trujillo Ferrara, Itzia Irene Padilla-Martínez, Héctor González-Espinosa, Antonio Abad-García, Eunice D Farfán-García, Clara Ortega-Camarillo, Alejandra Contreras-Ramos, Marvin Antonio Soriano-Ursúa
One-Step Synthesis, Crystallography, and Acute Toxicity of Two Boron-Carbohydrate Adducts That Induce Sedation in Mice. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Ricardo Ivan Cordova-Chávez, José Guadalupe Trujillo Ferrara, Itzia Irene Padilla-Martínez, Héctor González-Espinosa, Antonio Abad-García, Eunice D Farfán-García, Clara Ortega-Camarillo, Alejandra Contreras-Ramos, Marvin Antonio Soriano-Ursúa
One-Step Synthesis, Crystallography, and Acute Toxicity of Two Boron-Carbohydrate Adducts That Induce Sedation in Mice. Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Yesica Abril Botello-Flores, Martha Yocupicio-Monroy, Norma Balderrábano-Saucedo, Alejandra Contreras-Ramos
A systematic review on the role of MSC-derived exosomal miRNAs in the treatment of heart failure. Molecular biology reports 49 (9) (2022)
Luis Edgar González-Sánchez, Clara Ortega-Camarillo, Alejandra Contreras-Ramos, Leticia Andrea Barajas-Nava
miRNAs as biomarkers for diagnosis of type 2 diabetes: A systematic review. Journal of diabetes 13 (10) (2021)
David Sánchez-Herrera, Alejandra Contreras-Ramos, Elva Jiménez-Hernández, Aurora Medina-Sansón, Silvia Giono-Cerezo, Carmen Maldonado-Bernal
NK Cell Subpopulation Is Altered and the Expression of TLR1 and TLR9 Is Decreased in Patients with Acute Lymphoblastic Leukemia. Journal of oncology 2021 (2021)
Icela Palma-Lara, Ana Elena Sánchez-Aldana, Elva Jiménez-Hernández, Octavio Martínez Villegas, Juan Carlos Nuñez-Enriquez, Juan Manuel Mejía-Aranguré, Sara A Ochoa, Juan Xicohtencatl-Cortes, Ariadnna Cruz-Córdova, Sergio Zavala-Vega, Mariana García-Jiménez, Alejandra Contreras-Ramos, José Refugio Torres-Nava, Guillermo Mora-Ramiro, José Arellano-Galindo
Variable Expression of Notch1 and Pax5 in Classical Hodgkin Lymphoma and Infection with Epstein-Barr in Pediatric Patients. Microorganisms 8 (6) (2020)

Alejandra Contreras-Ramos.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alejandra Contreras-Ramos